Debate Articles

New to the journal in 2011 are a series of interesting and topical Editorial Debates. Each debate will focus on specific questions within topical areas in an attempt to air the arguments for and against a particular intervention.

We are fortunate to initiate this series with two eminent clinical scientists, Professors Tallman and Grimwade debating the role of minimal residual disease monitoring in acute promyelocytic leukemia (APL).

The next series of debate will follow from Clare Harrison and Tiziano Barbui debating the risk of asprin thrombocythemia and more will follow throughout the year.

The debate articles will be available to read here:


Commissioned Editorial Debates
Volume 35, Issue 1, Pages 1-138 (January 2011) pages 3-7 (free)

  • 1
Article Title Author(s) Type Pages
Introduction to an occasional series

January 2011 (Vol. 35 | No. 1 | Pages 1-2)

David T. Bowen Editorial

free full text
1-2
Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia?

January 2011 (Vol. 35 | No. 1 | Pages 3-7)

David Grimwade, Martin S. Tallman Editorial

free full text
3-7
Aspirin in low-risk essential thrombocythemia, not so simple after all?

March 2011 (Vol. 35 | No. 3 | Pages 286-289)

Claire Harrison, Tiziano Barbui Editorial

free full text
286-289
  • 1